Keywords: kalypsys, starts, 2nd, ph, trial, pain, drug
Kalypsys starts 2nd Ph I trial of pain drug
Article | 30 April 2007
California, USA-based pharmaceutical company Kalypsys has initiated a second Phase I trial of its developmental agent KD7040, a topical formulation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
